Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenus
34,970
34,969
34,759
31,827
28,292
27,049
Croissance des revenus (H/H)
1%
1%
9%
12%
5%
-9%
Coût des ventes
18,314
18,315
18,309
17,332
14,882
13,469
Bénéfice brut
16,656
16,654
16,450
14,495
13,410
13,580
Vente, Général et Administration
9,527
9,527
9,594
8,704
7,484
6,972
Recherche et développement
1,378
1,277
1,332
1,131
1,013
804
Frais d'exploitation
12,470
12,467
11,967
10,348
9,527
9,113
Autres revenus (charges) non opérationnels
--
--
-155
-24
-23
-41
Bénéfice avant impôts
3,145
3,145
2,282
3,343
3,472
4,188
Charge d'impôt sur le revenu
870
869
628
915
956
1,187
Bénéfice net
2,258
2,258
1,638
2,412
2,491
2,970
Croissance du bénéfice net
38%
38%
-32%
-3%
-16%
-8%
Actions en circulation (diluées)
272.37
272.37
272.37
272.37
272.37
272.37
Variation des actions (H-H)
0%
0%
0%
0%
0%
0%
EPS (dilué)
8.29
8.29
6.01
8.85
9.14
10.9
Croissance du EPS
38%
38%
-32%
-3%
-16%
-8%
Flux de trésorerie libre
2,635
2,635
3,268
1,604
2,231
5,630
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
47.62%
47.62%
47.32%
45.54%
47.39%
50.2%
Marge opérationnelle
11.97%
11.97%
12.89%
13.02%
13.72%
16.51%
Marge bénéficiaire
6.45%
6.45%
4.71%
7.57%
8.8%
10.98%
Marge du flux de trésorerie libre
7.53%
7.53%
9.4%
5.03%
7.88%
20.81%
EBITDA
6,436
6,437
6,904
6,240
5,910
6,281
Marge EBITDA
18.4%
18.4%
19.86%
19.6%
20.88%
23.22%
D&A pour le résultat opérationnel
2,250
2,250
2,421
2,093
2,027
1,814
EBIT
4,186
4,187
4,483
4,147
3,883
4,467
Marge EBIT
11.97%
11.97%
12.89%
13.02%
13.72%
16.51%
Taux d'imposition effectif
27.66%
27.63%
27.51%
27.37%
27.53%
28.34%
Statistiques clés
Clôture préc.
$22.36
Prix d'ouverture
$21.97
Plage de la journée
$21.86 - $22.12
Plage de 52 semaines
$17.7 - $24.67
Volume
246
Volume moyen
1.9K
BPA (TTM)
0.84
Rendement en dividend
--
Capitalisation boursière
$5.6B
Qu’est-ce que Getinge AB ?
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 11,794 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.